These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
230 related items for PubMed ID: 30928333
1. Markers of bone turnover are reduced in patients with CF related diabetes; the role of glucose. Mathiesen IH, Hitz MF, Katzenstein TL, Oturai P, Skov M, Jørgensen NR, Jensen PO, Mikkelsen CR, Krogh-Madsen R, Pressler T, Faurholt-Jepsen D. J Cyst Fibros; 2019 May; 18(3):436-441. PubMed ID: 30928333 [Abstract] [Full Text] [Related]
2. Decreased markers of bone turnover in children and adolescents with type 1 diabetes. Madsen JOB, Herskin CW, Zerahn B, Jørgensen NR, Olsen BS, Pociot F, Johannesen J. Pediatr Diabetes; 2020 May; 21(3):505-514. PubMed ID: 31970841 [Abstract] [Full Text] [Related]
3. Association between serum levels of bone turnover markers and bone mineral density in men and women with type 2 diabetes mellitus. Zhao C, Liu G, Zhang Y, Xu G, Yi X, Liang J, Yang Y, Liang J, Ma C, Ye Y, Yu M, Qu X. J Clin Lab Anal; 2020 Apr; 34(4):e23112. PubMed ID: 31733013 [Abstract] [Full Text] [Related]
5. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China. Gao C, Qiao J, Li SS, Yu WJ, He JW, Fu WZ, Zhang ZL. Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899 [Abstract] [Full Text] [Related]
6. Thalassemic osteopathy: a new marker of bone deposition. Baldini M, Forti S, Orsatti A, Marcon A, Ulivieri FM, Airaghi L, Zanaboni L, Cappellini MD. Blood Cells Mol Dis; 2014 Jan; 52(2-3):91-4. PubMed ID: 24091145 [Abstract] [Full Text] [Related]
7. Differential impact of glucose administered intravenously or orally on bone turnover markers in healthy male subjects. Westberg-Rasmussen S, Starup-Linde J, Hermansen K, Holst JJ, Hartmann B, Vestergaard P, Gregersen S. Bone; 2017 Apr; 97():261-266. PubMed ID: 28126633 [Abstract] [Full Text] [Related]
13. Analysis of bone mineral density and turnover in patients with cystic fibrosis: associations between the IGF system and inflammatory cytokines. Street ME, Spaggiari C, Ziveri MA, Volta C, Federico G, Baroncelli GI, Bernasconi S, Saggese G. Horm Res; 2006 Apr; 66(4):162-8. PubMed ID: 16804317 [Abstract] [Full Text] [Related]
14. Changes of bone turnover markers after elderly hip fracture surgery. Li XP, Li XY, Yang MH, Zhu SW, Wu XB, Zhang P. J Bone Miner Metab; 2021 Mar; 39(2):237-244. PubMed ID: 32876727 [Abstract] [Full Text] [Related]
15. Bone turnover markers reference database in five Southeast Asian countries. Lee JK, Khor HM, Chotiyarnwong P, Unnanuntana A, Amphansap T, Li-Yu J, Cating-Cabral MT, Luceño V, Cao N, Tran T, Ang SB, Puvanendran R, Mat S. Bone; 2024 Oct; 187():117182. PubMed ID: 38945507 [Abstract] [Full Text] [Related]
16. An association between abnormal bone turnover, systemic inflammation, and osteoporosis in patients with chronic pancreatitis: a case-matched study. Duggan SN, Purcell C, Kilbane M, O'Keane M, McKenna M, Gaffney P, Ridgway PF, Boran G, Conlon KC. Am J Gastroenterol; 2015 Feb; 110(2):336-45. PubMed ID: 25623657 [Abstract] [Full Text] [Related]
19. The association between the triglyceride-glucose index and bone turnover markers in osteoporotic fractures patients aged 50 and above who are hospitalized for surgical intervention: a retrospective cross-sectional study. Xu J, Guo SH, Xu MZ, Li C, Gong YQ, Lu K. Front Endocrinol (Lausanne); 2024 Feb; 15():1418271. PubMed ID: 39359411 [Abstract] [Full Text] [Related]